remember it did say it already (per phone call) what the FDA wanted here was it to be "more prominent" (which is arguably subjective).
(The requirements will always be specific to the drug and indication)
Ann: FDA Letter Requires Patient Instruction Update, page-158
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.8¢ |
Change
0.008(2.03%) |
Mkt cap ! $680.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.058M | 2.795M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 97716 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 142440 | 9 |
View Market Depth
| Last trade - 15.50pm 09/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |